Brian Goff

Brian Goff

DirectoratAgios Pharmaceuticals· In proxies 2021–2025

Pay in FY2025-21% from the year before · Agios Pharmaceuticals stock -17.2% the same year

Brian Goff was paid $5.4M in FY2025 (Dec), down 21%. Agios Pharmaceuticals stock fell 17.2% that year.

Pay$100 in the stock at the end of FY20 → $63
Pay is from the Summary Compensation Table of each Agios Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Intellia TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. Agios PharmaceuticalsPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role -16%
  3. Intellia Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?